Figure 2From: Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: early resultsIPSS. International Prostate Symptoms Score (IPSS) changes (mean).Back to article page